Eli Lilly Zepbound Lawsuit - Search News

Eli Lilly threatens Zepbound copycat makers

CNBC on MSN · 2d

Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro

Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and Mounjaro.

Yahoo Finance · 2d

Eli Lilly is coming after makers of copycat versions of Zepbound

Eli Lilly (LLY) is taking legal action against makers of off-brand versions of its blockbuster diabetes and weight-loss drugs, Mounjaro and Zepbound.

Business Insider · 2d

Eli Lilly threatens Zepbound copycat makers after shortage, Bloomberg reports

Eli Lilly (LLY) is targeting additional drug compounders and telehealth companies that make copycat versions of its weight loss drug, with

Hims & Hers Health, Lilly and Zepbound

Seeking Alpha · 3h

Eli Lilly Vs. Hims & Hers In DTC Weight Loss Market? - There Is Only One Winner

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges. Find out who is the winner.

The Wall Street Journal on MSN · 1d

Hims & Hers Expands Weight Loss Offering, Adds Lilly’s Zepbound to Platform

Hims & Hers Health said it is expanding its weight-loss offerings with the addition of Eli Lilly & Co. Zepbound and generic liraglutide. The telehealth-consultation platform on Tuesday said it aimed to bring its customers more treatment options to best suit their needs.

Bloomberg on MSN · 2d

Hims to Sell Lilly’s Zepbound Through Telehealth Platform

Hims & Hers Health Inc.’s shares rose Tuesday after it said it was broadening its weight-loss offerings, adding access to brand name shots like Zepbound after previously focusing on cheaper versions made by compounding pharmacies.

The Pharma Letter7h

Lilly defends market with new action against GLP-1 compounders

With two new lawsuits, Eli Lilly (NYSE: LLY) has escalated its legal campaign against the makers of unauthorized versions of ...

2don MSN

Hims & Hers to sell Lilly's Zepbound on its telehealth platform

(Reuters) -Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's diabetes and weight-loss drugs on ...

2don MSN

Eli Lilly sues Strive and Empower as FDA lifts tirzepatide shortage status

Eli Lilly sues two compounders over tirzepatide after FDA lifts Zepbound, Mounjaro shortage status in key GLP-1 legal test.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results